Michael Edlund

1.0k citations

13 papers · 645 indexed · h-index 9

Impact in

Hepatology top 2%
- Hepatitis C virus research
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment

Papers in ⓘ

Hepatology 5
- Hepatitis C virus research 5
Immunology and Allergy 2

Co-authors: Pierre Raboisson (5 shared papers)Lotta Vrang (5 shared papers)Oliver Lenz (5 shared papers)Herman de Kock (5 shared papers)Tse‐I Lin (5 shared papers)Kenneth Simmen (5 shared papers)Lennart Hansson (5 shared papers)Katrien Vermeiren (2 shared papers)
Journals: European Journal of Biochemistry (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)European Journal of Medicinal Chemistry (1 paper)Journal of Biomedical Science (1 paper)Transgenic Research (1 paper)
Partner nations: Sweden Belgium United Kingdom

In The Last Decade

Michael Edlund

13 papers receiving 632 citations

Peers

Countries citing papers authored by Michael Edlund

Since Specialization

Citations

This map shows the geographic impact of Michael Edlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Edlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Edlund more than expected).

Fields of papers citing papers by Michael Edlund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Edlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Edlund. The network helps show where Michael Edlund may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Edlund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Edlund Line = papers co-authored together Michael Edlund links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 Antimicrobial Agents and Chemotherapy ·Oliver Lenz, Thierry Verbinnen, Tse‐I Lin, Leen Vijgen, Maxwell D. Cummings, Jimmy Lindberg, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Annick Scholliers, Katrien Vermeiren, Tania Ivens, Pierre Raboisson, Michael Edlund, Susan Storm, Lotta Vrang, Herman de Kock, Gregory Fanning, Kenneth Simmen	2010	178
2	In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor Antimicrobial Agents and Chemotherapy ·Tse‐I Lin, Oliver Lenz, Gregory Fanning, Thierry Verbinnen, Frédéric Delouvroy, Annick Scholliers, Katrien Vermeiren, Åsa Rosenquist, Michael Edlund, Bertil Samuelsson, Lotta Vrang, Herman de Kock, Piet Wigerinck, Pierre Raboisson, Kenneth Simmen	2009	142
3	Epidermal Overexpression of Stratum Corneum Chymotryptic Enzyme in Mice: A Model for Chronic Itchy Dermatitis Journal of Investigative Dermatology ·Assar Bäckman, Annelii Ny, Michael Edlund, Elisabeth Ekholm, Barbro Ekstrand Hammarström, Jan Törnell, Pia Wallbrandt, Torbjörn Egelrud, Lennart Hansson, Håkan Wennbo	2002	133
4	Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target Angewandte Chemie International Edition ·Maxwell D. Cummings, Jimmy Lindberg, Tse‐I Lin, Herman de Kock, Oliver Lenz, Elisabet Lilja, Sara Felländer, Vera Baraznenok, Susanne Nyström, Magnus Nilsson, Lotta Vrang, Michael Edlund, Åsa Rosenquist, Bertil Samuelsson, Pierre Raboisson, Kenneth Simmen	2010	71
5	BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells Journal of Biomedical Science ·Anne Jämsä, Oscar Belda, Michael Edlund, Erik Lindström	2011	25
6	Recombinant Human-Milk Bile-Salt-Stimulated Lipase. Functional Properties are Retained in the Absence of Glycosylation and the Unique Proline-Rich Repeats European Journal of Biochemistry ·Lars Bläckberg, Mats Strömqvist, Michael Edlund, Kristina Juneblad, Lennart Lundberg, Lennart Hansson, Olle Hernell	1995	24
7	Recombinant human bile salt-stimulated lipase: an example of defectiveO-glycosylation of a protein produced in milk of transgenic mice Transgenic Research ·Mats Strömqvist, Jan Törnell, Michael Edlund, A. Edlund, Thore Johansson, Kerstin Lindgren, Lennart Lundberg, Lennart Hansson	1996	20
8	Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core European Journal of Medicinal Chemistry ·Fredrik Wångsell, Karin Gustafsson, Ingemar Kvarnström, Neera Borkakoti, Michael Edlund, Katarina Jansson, Jimmy Lindberg, Anders Hallberg, Åsa Rosenquist, Bertil Samuelsson	2009	19
9	Recombinant Human-Milk Bile-Salt-Stimulated Lipase. Functional Properties are Retained in the Absence of Glycosylation and the Unique Proline-Rich Repeats European Journal of Biochemistry ·Lars Bläckberg, Mats Strömqvist, Michael Edlund, Kristina Juneblad, Lennart Lundberg, Lennart Hansson, Olle Hernell	1995	13
10	Properties of recombinant human plasma procarboxypeptidase U produced in mammalian and insect cells Clinica Chimica Acta ·Mats Strömqvist, Lennart Hansson, Jan-Olof Andersson, T. Johansson, Michael Edlund, Maria Enoksson, Filip Goossens, Simon Scharpé, Dirk Hendriks	2004	8
11	The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K Bone ·K. Fuller, Erik Lindström, Michael Edlund, Ian Henderson, Urszula Grabowska, Kinga Szewczyk, Raymond F. Moss, Bertil Samuelsson, Timothy Chambers	2010	7
12	Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target Angewandte Chemie ·Maxwell D. Cummings, Jimmy Lindberg, Tse‐I Lin, Herman de Kock, Oliver Lenz, Elisabet Lilja, Sara Felländer, Vera Baraznenok, Susanne Nyström, Magnus Nilsson, Lotta Vrang, Michael Edlund, Åsa Rosenquist, Bertil Samuelsson, Pierre Raboisson, Kenneth Simmen	2010	4
13	Innentitelbild: Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target (Angew. Chem. 9/2010) Angewandte Chemie ·Maxwell D. Cummings, Jimmy Lindberg, Tse‐I Lin, Herman de Kock, Oliver Lenz, Elisabet Lilja, Sara Felländer, Vera Baraznenok, Susanne Nyström, Magnus Nilsson, Lotta Vrang, Michael Edlund, Åsa Rosenquist, Bertil Samuelsson, Pierre Raboisson, Kenneth Simmen	2010	1

About Michael Edlund

Michael Edlund is a scholar working on Hepatology, Immunology and Allergy, Computational Theory and Mathematics, Radiology, Nuclear Medicine and Imaging and Orthopedics and Sports Medicine, having authored 13 papers that have together received 645 indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Pancreatic function and diabetes (3 papers), Computational Drug Discovery Methods (3 papers), Carbohydrate Chemistry and Synthesis (2 papers), Hepatitis B Virus Studies (2 papers), Enzyme Catalysis and Immobilization (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Hepatology (337 citations), Infectious Diseases (196 citations), Dermatology (88 citations), Immunology and Allergy (48 citations) and Epidemiology (253 citations). Michael Edlund has collaborated with scholars based in Sweden, Belgium and United Kingdom. Frequent co-authors include Pierre Raboisson, Lotta Vrang, Oliver Lenz, Herman de Kock, Tse‐I Lin, Kenneth Simmen, Lennart Hansson, Katrien Vermeiren, Gregory Fanning and Thierry Verbinnen. Their work appears in journals such as European Journal of Biochemistry, Antimicrobial Agents and Chemotherapy, European Journal of Medicinal Chemistry, Journal of Biomedical Science and Transgenic Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact